Acromegaly is a rare condition that presents with common symptoms. However, if left undiagnosed, it may lead to serious complications and premature death. This Patient Health Management (PHM) program will allow physicians to gain enhanced practical knowledge to detect patients with acromegaly early and minimize the diagnostic gap, leading to treating patients early and improving patients’ quality of life.
This program has received financial support and an unrestricted educational grant from Ipsen Biopharmaceuticals Canada Inc.